Accelence : the single point of contact for the support and the development of Bordeaux University Hospital industry-sponsored clinical research
Since June the 1st, 2016, Bordeaux University Hospital has set up a new organization for the conduct of industry sponsored clinical trials in conjunction with ACCELENCE. Since more than 5 years, ACCELENCE has demonstrated its expertise in the field of the support to clinical investigation and its proactivity, resulting in an enhanced attractiveness of the Bordeaux University Hospital for the conduct of national and international industry sponsored clinical trials.
The Bordeaux University Hospital now positions ACCELENCE as its single point of contact for the implementation and the follow up of industry’s sponsored clinical trials.
4st Scientific and Industrial Committee
September the 22th, 2015, many Clinical Research players attended the 4th edition of the Scientific and Industrial Committee of ACCELENCE which was held at the IHU LIRYC in Pessac.
During this meeting, opened by Professor Nicholas MOORE, Chairman of ACCELENCE and by Mr. VIGOUROUX, CEO of University Hospital of Bordeaux, 28 representatives of the health Industry (Pharmaceutical companies, medical device manufacturers, CRO), 21 key opinion leaders from a large spectrum of disease areas, as well as numerous institutions partners have discussed about issues on ” the innovation coming from the hospital toward a market.
Also, this Council was higjlighted by the signing of a Partnership Agreement with Novartis and by the renewal of the Prime Site Partnership with Quintiles.
Download the 4th Scientific and Industrial Committee presentations :
Pr. Alain TAIEB, Head of the Dermatology Unit at the Bordeaux University Hospital and Mr. Jean-Jacques VOISARD, Head of PIERRE FABRE DERMATOLOGY : Hemangiol Project – The Story of a Perfect Partnership Public-Private